May 1st 2025
Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.
Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.
April 29th 2025
April 24th 2025
AI is transforming content reviews to focus on relevant use, not just generation.
April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
Colombia Set for Strong Pharma Market Growth
October 19, 2016
NICE Announces Fast-Track Approval Plans
October 18, 2016
Astellas to Help Tackle Doping in Sports
October 14, 2016
UN Competition Policy Meeting to Discuss Big Pharma 'Tactics'
Advaxis Approved for $2.5 Million Tax Credit from New Jersey's NOL Program
October 13, 2016
Major Depressive Disorder Market to Reach $5.8 Billion by 2025
October 12, 2016
Medical Tourism Will Help Push UAE Pharma Market to $5.6 Billion by 2020
October 11, 2016
Mylan Reaches Settlement with Department of Justice
Department of Veterans Affairs Awards Genome Sequencing Contract
October 7, 2016
Gastrointestinal Drugs Market to Hit $48.4 Billion by 2022
Lifetime Achievement Award for Cancer Clinician
October 6, 2016
TTIP Could "Lock Europe and US into Higher Drug Prices, Failed Pharma Innovation Model"
October 5, 2016
US to Lose Dominance of Generics Market
Outlook for Biosimilars in 2020
October 3, 2016
Malaysian Pharma Market Set to Reach $3.6 billion by 2020
Counterfeit Drugs Cost Europe More Than €10 Billion a Year
FDA Approves Fourth Biosimilar
September 26, 2016
Tufts CSDD Releases Findings from Diabetes Study
EpiPen Controversy: Mylan CEO Faces Congressional Committee
September 22, 2016
EMA Determines Certain Drugs Safe from Zika Contamination
Australian Pharma Market Set for "Modest Growth" to 2020
Eleven Biotherapeutics Acquires Canada's Viventia Bio
September 21, 2016
Australia Plans to Expedite Drug Approval Process
September 20, 2016
Osteoarthritis Market "to Treble by 2024"
New GSK Chief "Most Powerful Woman in FTSE 100"
EMA Blocks Imports from US's Pharmaceutics International
September 19, 2016
NICE Sets Out Proposed Technology Assessment Fees
Leela Barham looks at the potential cost to industry of the National Institute for Health and Care Excellence's plans to charge for TAs.
FDA Director Responds to Drug Pricing Concerns
September 16, 2016
EFPIA Calls for Urgent Action on Antimicrobial Resistance
September 15, 2016
Sanofi Appoints New North America CSO
September 14, 2016